Source 1review2022Frontiers in Cell and Developmental Biology
Toolkit/delivery system
delivery system
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
This entry describes delivery-system choice as a genome-editing optimization strategy rather than a single defined molecular reagent. In the cited 2022 review, delivery-system selection is presented as one approach for improving the efficiency of CRISPR/Cas-induced mutations.
Usefulness & Problems
Why this is useful
The strategy is useful because the review identifies unsatisfactory delivery efficiency as an inherent limitation of CRISPR/Cas applications. Framing delivery-system choice as an optimization lever supports efforts to improve editing performance across the many organisms and cell types in which CRISPR/Cas systems are used.
Problem solved
This approach addresses the specific problem of inefficient delivery in CRISPR/Cas genome editing. The cited review places delivery-system choice among broader strategies intended to increase the efficiency of CRISPR/Cas-induced mutation generation.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Mechanisms
No mechanism tags yet.
Techniques
No technique tags yet.
Target processes
editingImplementation Constraints
The available evidence only supports that delivery-system choice is considered during CRISPR/Cas experimental design to improve mutation efficiency. It does not specify construct architecture, formulation, expression system, dosing, or delivery modality.
The evidence does not define a specific delivery vehicle, cargo format, organism, or experimental benchmark for this entry. No quantitative performance data, comparative validation, or mechanistic details for any particular delivery system are provided in the supplied evidence.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The review states that CRISPR/Cas systems have inherent limitations including off-target effects, unsatisfactory delivery efficiency, and unwanted adverse effects.
CRISPR/Cas systems have some inherent limitations, such as off-target effects, unsatisfactory efficiency of delivery, and unwanted adverse effects
The review states that CRISPR/Cas systems have inherent limitations including off-target effects, unsatisfactory delivery efficiency, and unwanted adverse effects.
CRISPR/Cas systems have some inherent limitations, such as off-target effects, unsatisfactory efficiency of delivery, and unwanted adverse effects
The review states that CRISPR/Cas systems have inherent limitations including off-target effects, unsatisfactory delivery efficiency, and unwanted adverse effects.
CRISPR/Cas systems have some inherent limitations, such as off-target effects, unsatisfactory efficiency of delivery, and unwanted adverse effects
The review states that CRISPR/Cas systems have inherent limitations including off-target effects, unsatisfactory delivery efficiency, and unwanted adverse effects.
CRISPR/Cas systems have some inherent limitations, such as off-target effects, unsatisfactory efficiency of delivery, and unwanted adverse effects
The review states that CRISPR/Cas systems have inherent limitations including off-target effects, unsatisfactory delivery efficiency, and unwanted adverse effects.
CRISPR/Cas systems have some inherent limitations, such as off-target effects, unsatisfactory efficiency of delivery, and unwanted adverse effects
The review states that CRISPR/Cas systems have inherent limitations including off-target effects, unsatisfactory delivery efficiency, and unwanted adverse effects.
CRISPR/Cas systems have some inherent limitations, such as off-target effects, unsatisfactory efficiency of delivery, and unwanted adverse effects
The review states that CRISPR/Cas systems have revolutionized traditional gene-editing tools and show broad potential for genetic manipulation across many organisms and cell types.
CRISPR/Cas systems have revolutionized traditional gene-editing tools ... have displayed tremendous potential for genetic manipulation in almost any organism and cell type.
The review states that CRISPR/Cas systems have revolutionized traditional gene-editing tools and show broad potential for genetic manipulation across many organisms and cell types.
CRISPR/Cas systems have revolutionized traditional gene-editing tools ... have displayed tremendous potential for genetic manipulation in almost any organism and cell type.
The review states that CRISPR/Cas systems have revolutionized traditional gene-editing tools and show broad potential for genetic manipulation across many organisms and cell types.
CRISPR/Cas systems have revolutionized traditional gene-editing tools ... have displayed tremendous potential for genetic manipulation in almost any organism and cell type.
The review states that CRISPR/Cas systems have revolutionized traditional gene-editing tools and show broad potential for genetic manipulation across many organisms and cell types.
CRISPR/Cas systems have revolutionized traditional gene-editing tools ... have displayed tremendous potential for genetic manipulation in almost any organism and cell type.
The review states that CRISPR/Cas systems have revolutionized traditional gene-editing tools and show broad potential for genetic manipulation across many organisms and cell types.
CRISPR/Cas systems have revolutionized traditional gene-editing tools ... have displayed tremendous potential for genetic manipulation in almost any organism and cell type.
The review states that CRISPR/Cas systems have revolutionized traditional gene-editing tools and show broad potential for genetic manipulation across many organisms and cell types.
CRISPR/Cas systems have revolutionized traditional gene-editing tools ... have displayed tremendous potential for genetic manipulation in almost any organism and cell type.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review describes improving sgRNA design and modification as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... improving the design and modification of sgRNA ... are comprehensively described in this review.
The review discusses Cas variants, anti-CRISPR proteins, and mutant enrichment as newly emerging approaches relevant to improving CRISPR/Cas system use.
several newly emerging approaches, including the use of Cas variants, anti-CRISPR proteins, and mutant enrichment, are discussed in detail
The review discusses Cas variants, anti-CRISPR proteins, and mutant enrichment as newly emerging approaches relevant to improving CRISPR/Cas system use.
several newly emerging approaches, including the use of Cas variants, anti-CRISPR proteins, and mutant enrichment, are discussed in detail
The review discusses Cas variants, anti-CRISPR proteins, and mutant enrichment as newly emerging approaches relevant to improving CRISPR/Cas system use.
several newly emerging approaches, including the use of Cas variants, anti-CRISPR proteins, and mutant enrichment, are discussed in detail
The review discusses Cas variants, anti-CRISPR proteins, and mutant enrichment as newly emerging approaches relevant to improving CRISPR/Cas system use.
several newly emerging approaches, including the use of Cas variants, anti-CRISPR proteins, and mutant enrichment, are discussed in detail
The review discusses Cas variants, anti-CRISPR proteins, and mutant enrichment as newly emerging approaches relevant to improving CRISPR/Cas system use.
several newly emerging approaches, including the use of Cas variants, anti-CRISPR proteins, and mutant enrichment, are discussed in detail
The review discusses Cas variants, anti-CRISPR proteins, and mutant enrichment as newly emerging approaches relevant to improving CRISPR/Cas system use.
several newly emerging approaches, including the use of Cas variants, anti-CRISPR proteins, and mutant enrichment, are discussed in detail
Approval Evidence
1 source1 linked approval claimfirst-pass slug delivery-system
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
Source:
strategy summarysupports
The review describes choice of delivery system as a strategy for improving the efficiency of CRISPR/Cas-induced mutations.
Strategies for improving the efficiency of CRISPR/Cas-induced mutations, such as ... choice of delivery system ... are comprehensively described in this review.
Source:
Comparisons
Source-backed strengths
A strength of this concept is its broad applicability, because the review describes CRISPR/Cas systems as having potential across many organisms and cell types. The evidence also supports delivery optimization as an explicitly recognized strategy for improving editing efficiency.
Ranked Citations
- 1.